Understanding the role of ETS-mediated gene regulation in complex biological processes.

[1]  M. Stern,et al.  MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor , 2013, Oncogene.

[2]  Yongmun Choi,et al.  A-62176, a potent topoisomerase inhibitor, inhibits the expression of human epidermal growth factor receptor 2. , 2012, Cancer letters.

[3]  Bruce G. Haffty,et al.  Elf5 Inhibits Epithelial Mesenchymal Transition in Mammary Gland Development and Breast Cancer Metastasis by Transcriptionally Repressing Snail2/slug Hhs Public Access Elf5 Knockdown in Epithelial-like T47d Breast Cancer Cells Induces Emt Elf5 Promotes Mesenchymal-epithelial Transition (met) in Mda- , 2022 .

[4]  A. Gutierrez-Hartmann,et al.  Control of MicroRNA-21 expression in colorectal cancer cells by oncogenic epidermal growth factor/Ras signaling and Ets transcription factors. , 2012, DNA and cell biology.

[5]  W. de Lau,et al.  Peyer's Patch M Cells Derived from Lgr5+ Stem Cells Require SpiB and Are Induced by RankL in Cultured “Miniguts” , 2012, Molecular and Cellular Biology.

[6]  Yibin Kang,et al.  Elf5 Regulates Mammary Gland Stem/Progenitor Cell Fate by Influencing Notch Signaling , 2012, Stem cells.

[7]  K. Tsui,et al.  Upregulation of prostate‐derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells , 2012, International journal of cancer.

[8]  Y. Akao,et al.  Expression of BMP‐2 and Ets1 in BMP‐2‐stimulated mouse pre‐osteoblast differentiation is regulated by microRNA‐370 , 2012, FEBS letters.

[9]  T. Kaisho,et al.  The Ets Transcription Factor Spi-B Is Essential for the Differentiation of Intestinal Microfold (M) Cells , 2012, Nature Immunology.

[10]  D. Lim,et al.  Transcription Factors ER71/ETV2 and SOX9 Participate in a Positive Feedback Loop in Fetal and Adult Mouse Testis* , 2012, The Journal of Biological Chemistry.

[11]  B. Arnulf,et al.  The Ets-1 transcription factor is required for Stat1-mediated T-bet expression and IgG2a class switching in mouse B cells. , 2012, Blood.

[12]  B. Torbett,et al.  Transcriptional regulation of MIR29B by PU.1 (SPI1) and MYC during neutrophil differentiation of acute promyelocytic leukaemia cells , 2012, British journal of haematology.

[13]  Douglas Hanahan,et al.  Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types , 2022 .

[14]  Baoan Chen,et al.  Gambogic acid-loaded magnetic Fe3O4 nanoparticles inhibit Panc-1 pancreatic cancer cell proliferation and migration by inactivating transcription factor ETS1 , 2012, International journal of nanomedicine.

[15]  Philip J. Monroe,et al.  Single Enantiomer of YK-4-279 Demonstrates Specificity in Targeting the Oncogene EWS-FLI1 , 2012, Oncotarget.

[16]  Sung-Chou Li,et al.  Transcriptional regulation of miR-196b by ETS2 in gastric cancer cells , 2012, Carcinogenesis.

[17]  P. Jedlicka,et al.  A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs , 2011, Oncogene.

[18]  David P Turner,et al.  Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression , 2011, The Prostate.

[19]  Michael C. Ostrowski,et al.  Reprogramming of the Tumor Microenvironment by Stromal Pten-regulated miR-320 , 2011, Nature Cell Biology.

[20]  F. Soncin,et al.  Evaluation of effects caused by differentially spliced Ets-1 transcripts in fibroblasts. , 2011, International journal of oncology.

[21]  B. Ebert,et al.  Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome. , 2011, Blood.

[22]  Peter C. Hollenhorst,et al.  Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells. , 2011, Genes & development.

[23]  Ya-Ni Tsai,et al.  The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility. , 2011, Blood.

[24]  Nicolò Riggi,et al.  Let-7a Is a Direct EWS-FLI-1 Target Implicated in Ewing's Sarcoma Development , 2011, PloS one.

[25]  Zhiyv Niu,et al.  MicroRNA-21 regulates the self-renewal of mouse spermatogonial stem cells , 2011, Proceedings of the National Academy of Sciences.

[26]  Wei Yan,et al.  BASIC AND TRANSLATIONAL — ALIMENTARY TRACT Serum Response Factor – Dependent MicroRNAs Regulate Gastrointestinal Smooth Muscle Cell Phenotypes , 2011 .

[27]  K. Leong,et al.  COP1 is a tumour suppressor that causes degradation of ETS transcription factors , 2011, Nature.

[28]  Peter C. Hollenhorst,et al.  Genomic and biochemical insights into the specificity of ETS transcription factors. , 2011, Annual review of biochemistry.

[29]  A. Papavassiliou,et al.  Seeing the future of cancer-associated transcription factor drug targets. , 2011, JAMA.

[30]  A. Okuducu,et al.  Identification of ETS-1 target genes in human fibroblasts. , 2011, International journal of oncology.

[31]  Wenlin Huang,et al.  miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. , 2011, Cancer research.

[32]  D. Strunk,et al.  Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma , 2011, Oncogene.

[33]  A. Üren,et al.  YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion , 2011, PloS one.

[34]  W. Yuan,et al.  Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration , 2011, Heart.

[35]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[36]  D. Ye,et al.  Ets-1: a new player in the pathogenesis of systemic lupus erythematosus? , 2011, Lupus.

[37]  K. Hikami,et al.  Association of a functional polymorphism in the 3'-untranslated region of SPI1 with systemic lupus erythematosus. , 2011, Arthritis and rheumatism.

[38]  G. A. Wilkinson,et al.  Fli + etsrp + Hemato-Vascular Progenitor Cells Proliferate at the Lateral Plate Mesoderm during Vasculogenesis in Zebrafish , 2011, PloS one.

[39]  Chyung-Ru Wang,et al.  Differential requirements for the Ets transcription factor Elf-1 in the development of NKT cells and NK cells. , 2011, Blood.

[40]  E. Thiel,et al.  The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia. , 2011, Leukemia research.

[41]  David P Turner,et al.  Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms. , 2011, Genes & cancer.

[42]  R. Yeh,et al.  TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a. , 2010, Blood.

[43]  F. Morlé,et al.  Inducible Fli-1 gene deletion in adult mice modifies several myeloid lineage commitment decisions and accelerates proliferation arrest and terminal erythrocytic differentiation. , 2010, Blood.

[44]  G. Gilkeson,et al.  A GA microsatellite in the Fli1 promoter modulates gene expression and is associated with systemic lupus erythematosus patients without nephritis , 2010, Arthritis research & therapy.

[45]  G. Gilkeson,et al.  Impact of Fli‐1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice , 2010, Clinical and experimental immunology.

[46]  Hua-Chien Chen,et al.  EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. , 2010, Cancer research.

[47]  C. Artlett.  Animal models of scleroderma: fresh insights , 2010, Current opinion in rheumatology.

[48]  Nicholas Bertos,et al.  miR-378(∗) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway. , 2010, Cell metabolism.

[49]  Yi Tie,et al.  MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells. , 2010, European journal of cancer.

[50]  P. Oettgen,et al.  Ets-1 and Ets-2 Regulate the Expression of MicroRNA-126 in Endothelial Cells , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[51]  L. Olson,et al.  The Ets-1 transcription factor controls the development and function of natural regulatory T cells , 2010, The Journal of experimental medicine.

[52]  Michael C. Ostrowski,et al.  ETS Transcription Factors in the Tumor Microenvironment , 2010 .

[53]  V. Findlay,et al.  ETS Transcription Factor Expression and Conversion During Prostate and Breast Cancer Progression , 2010 .

[54]  G. Gilkeson,et al.  Thrombocytopenia in Mice Lacking the Carboxy-Terminal Regulatory Domain of the Ets Transcription Factor Fli1 , 2010, Molecular and Cellular Biology.

[55]  Y. Asano,et al.  The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis. , 2010, Journal of dermatological science.

[56]  U. Gündüz,et al.  Drug resistant breast cancer cells overexpress ETS1 gene. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[57]  M. Bhasin,et al.  Requirement of the Epithelium-specific Ets Transcription Factor Spdef for Mucous Gland Cell Function in the Gastric Antrum* , 2010, The Journal of Biological Chemistry.

[58]  R. Treisman,et al.  Ternary Complex Factors SAP-1 and Elk-1, but Not Net, Are Functionally Equivalent in Thymocyte Development , 2010, The Journal of Immunology.

[59]  Y. Akao,et al.  MicroRNA-208 Modulates BMP-2-stimulated Mouse Preosteoblast Differentiation by Directly Targeting V-ets Erythroblastosis Virus E26 Oncogene Homolog 1* , 2010, The Journal of Biological Chemistry.

[60]  R. Meacham,et al.  Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEF , 2010, Molecular Cancer.

[61]  S. Oparil,et al.  The Transcription Factor ETS-1 Mediates Proinflammatory Responses and Neointima Formation in Carotid Artery Endoluminal Vascular Injury , 2010, Hypertension.

[62]  Andrew R. Gehrke,et al.  Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo , 2010, The EMBO journal.

[63]  J. Mendell,et al.  Myc: Maestro of MicroRNAs. , 2010, Genes & cancer.

[64]  Nicolò Riggi,et al.  EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. , 2010, Genes & development.

[65]  T. Enver,et al.  Tel1/ETV6 specifies blood stem cells through the agency of VEGF signaling. , 2010, Developmental cell.

[66]  D. Watson,et al.  Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. , 2010, The American journal of pathology.

[67]  Michael C. Ostrowski,et al.  An ets2-driven transcriptional program in tumor-associated macrophages promotes tumor metastasis. , 2010, Cancer research.

[68]  L. Garrett-Sinha,et al.  Deletion of ETS-1, a gene in the Jacobsen syndrome critical region, causes ventricular septal defects and abnormal ventricular morphology in mice. , 2010, Human molecular genetics.

[69]  Raja Jothi,et al.  Critical Requirement of GABPα for Normal T Cell Development* , 2010, The Journal of Biological Chemistry.

[70]  David P Turner,et al.  Transcriptional Regulation of p21/CIP1 Cell Cycle Inhibitor by PDEF Controls Cell Proliferation and Mammary Tumor Progression* , 2010, The Journal of Biological Chemistry.

[71]  Y. Pilpel,et al.  p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC , 2010, Cell Death and Differentiation.

[72]  P. Sham,et al.  Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus , 2010, PLoS genetics.

[73]  E. Small,et al.  Emerging biological observations in prostate cancer , 2010, Expert review of anticancer therapy.

[74]  David P Turner,et al.  PDEF is a negative regulator of colon cancer cell growth and migration , 2009, Journal of cellular biochemistry.

[75]  V. Álvarez,et al.  A functional polymorphism in MMP1 could influence osteomyelitis development , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[76]  Barbara J. Graves,et al.  DNA Specificity Determinants Associate with Distinct Transcription Factor Functions , 2009, PLoS genetics.

[77]  E. Larsson,et al.  Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1 , 2009, Genome Medicine.

[78]  Karen D. Cowden Dahl,et al.  The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. , 2009, Neoplasia.

[79]  E. Kikuchi,et al.  Ets‐1 and hypoxia inducible factor‐1α inhibition by angiotensin II type‐1 receptor blockade in hormone‐refractory prostate cancer , 2009, The Prostate.

[80]  P. Farnham.  Insights from genomic profiling of transcription factors , 2009, Nature Reviews Genetics.

[81]  Elizabeth A. Kruse,et al.  Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage , 2009, Proceedings of the National Academy of Sciences.

[82]  Michael C. Ostrowski,et al.  Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. , 2009, Blood.

[83]  Michael D. Wilson,et al.  ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. , 2009, Methods.

[84]  R. Ferrante,et al.  Activation of Ets‐2 by oxidative stress induces Bcl‐xL expression and accounts for glial survival in amyotrophic lateral sclerosis , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[85]  R. Shah,et al.  The Discovery of Common Recurrent Transmembrane Protease Serine 2 (TMPRSS2)-Erythroblastosis Virus E26 Transforming Sequence (ETS) Gene Fusions in Prostate Cancer: Significance and Clinical Implications , 2009, Advances in anatomic pathology.

[86]  Jamie M. Verheyden,et al.  FGF-regulated Etv genes are essential for repressing Shh expression in mouse limb buds. , 2009, Developmental cell.

[87]  A. Visel,et al.  ChIP-seq accurately predicts tissue-specific activity of enhancers , 2009, Nature.

[88]  Y. Asano,et al.  Phosphorylation of Fli1 at Threonine 312 by Protein Kinase C δ Promotes Its Interaction with p300/CREB-Binding Protein-Associated Factor and Subsequent Acetylation in Response to Transforming Growth Factor β , 2009, Molecular and Cellular Biology.

[89]  R. Hammer,et al.  Nkx2–5 transactivates the Ets-related protein 71 gene and specifies an endothelial/endocardial fate in the developing embryo , 2009, Proceedings of the National Academy of Sciences.

[90]  K. Murphy,et al.  Critical role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis , 2008, Nature.

[91]  D. Watson,et al.  Transcription Factor Fli1 Regulates Collagen Fibrillogenesis in Mouse Skin , 2008, Molecular and Cellular Biology.

[92]  Mauro Biffoni,et al.  MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets‐1 and Meis1 transcription factors , 2008, British journal of haematology.

[93]  David P Turner,et al.  MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer. , 2008, Cancer research.

[94]  P. Allavena,et al.  Macrophage polarization in tumour progression. , 2008, Seminars in cancer biology.

[95]  V. Findlay,et al.  Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression. , 2008, Molecular biology of the cell.

[96]  F. Liu,et al.  Fli1 Acts at the Top of the Transcriptional Network Driving Blood and Endothelial Development , 2008, Current Biology.

[97]  G. Gilkeson,et al.  The Transcription Factor Fli-1 Modulates Marginal Zone and Follicular B Cell Development in Mice1 , 2008, The Journal of Immunology.

[98]  Elizabeth A. Kruse,et al.  The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells , 2008, Nature Immunology.

[99]  Karen D. Cowden Dahl,et al.  Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. , 2008, Cancer research.

[100]  Jae Hoon Kim,et al.  MicroRNA Expression Profiles in Serous Ovarian Carcinoma , 2008, Clinical Cancer Research.

[101]  C. Bodemer,et al.  A frequent functional SNP in the MMP1 promoter is associated with higher disease severity in recessive dystrophic epidermolysis bullosa , 2008, Human mutation.

[102]  D. Turner,et al.  ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer , 2008, Expert review of anticancer therapy.

[103]  Y. Asano,et al.  Transforming Growth Factor-β Regulates DNA Binding Activity of Transcription Factor Fli1 by p300/CREB-binding Protein-associated Factor-dependent Acetylation* , 2007, Journal of Biological Chemistry.

[104]  Berthold Göttgens,et al.  Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development , 2007, Proceedings of the National Academy of Sciences.

[105]  Qing-zhang Li,et al.  Identification of differentially expressed microRNAs during the development of Chinese murine mammary gland. , 2007, Journal of genetics and genomics = Yi chuan xue bao.

[106]  Gregory J. Hannon,et al.  microRNAs join the p53 network — another piece in the tumour-suppression puzzle , 2007, Nature Reviews Cancer.

[107]  David P Turner,et al.  Defining ETS transcription regulatory networks and their contribution to breast cancer progression , 2007, Journal of cellular biochemistry.

[108]  Ross Tubo,et al.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.

[109]  I. Mills,et al.  New androgen receptor genomic targets show an interaction with the ETS1 transcription factor , 2007, EMBO reports.

[110]  S. Dhanasekaran,et al.  Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer , 2007, Nature.

[111]  E. Mardis.  ChIP-seq: welcome to the new frontier , 2007, Nature Methods.

[112]  Peter C. Hollenhorst,et al.  Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. , 2007, Genes & development.

[113]  Rakesh Kumar,et al.  Phosphorylation-dependent Regulation of Stability and Transforming Potential of ETS Transcriptional Factor ESE-1 by p21-activated Kinase 1* , 2007, Journal of Biological Chemistry.

[114]  E. Wiemer.  The role of microRNAs in cancer: no small matter. , 2007, European journal of cancer.

[115]  B. Rubino,et al.  The role of epithelial-mesenchymal transition in cancer pathology. , 2007, Pathology.

[116]  J. Cross,et al.  Transcriptional Repressor Erf Determines Extraembryonic Ectoderm Differentiation , 2007, Molecular and Cellular Biology.

[117]  A. Gutierrez-Hartmann,et al.  ETS transcription factors in endocrine systems , 2007, Trends in Endocrinology & Metabolism.

[118]  C. Sen,et al.  MicroRNA in cutaneous wound healing: a new paradigm. , 2007, DNA and cell biology.

[119]  Kwon-Sik Park,et al.  SPDEF regulates goblet cell hyperplasia in the airway epithelium. , 2007, The Journal of clinical investigation.

[120]  Todd R Golub,et al.  Signature-Based Small Molecule Screening Identifies Cytosine Arabinoside as an EWS/FLI Modulator in Ewing Sarcoma , 2007, PLoS medicine.

[121]  P. Hertzog,et al.  TGF-betaRII rescues development of small intestinal epithelial cells in Elf3-deficient mice. , 2007, Gastroenterology.

[122]  I. Kola,et al.  Targeting of the ETS Factor Gabpα Disrupts Neuromuscular Junction Synaptic Function , 2007, Molecular and Cellular Biology.

[123]  David P Turner,et al.  Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer. , 2007, Cancer research.

[124]  M. Markiewicz,et al.  Fli1 and Ets1 Have Distinct Roles in Connective Tissue Growth Factor/CCN2 Gene Regulation and Induction of the Profibrotic Gene Program* , 2006, Journal of Biological Chemistry.

[125]  A. Larue,et al.  Molecular mechanisms of megakaryopoiesis , 2006, Cellular and Molecular Life Sciences CMLS.

[126]  Robert A. Weinberg,et al.  Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type , 2006, Cell cycle.

[127]  P. Maroni,et al.  HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-κB , 2006 .

[128]  I. Panagopoulos,et al.  Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer , 2006 .

[129]  B. Kahaleh,et al.  Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. , 2006, Arthritis and rheumatism.

[130]  A. Okuducu,et al.  Expression pattern of matrix metalloproteinase and TIMP genes in fibroblasts derived from Ets-1 knock-out mice compared to wild-type mouse fibroblasts. , 2006, International journal of molecular medicine.

[131]  W. Gerald,et al.  An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen , 2006, Oncogene.

[132]  N. Rajewsky.  microRNA target predictions in animals , 2006, Nature Genetics.

[133]  M. Uesugi,et al.  Small organic molecules that modulate gene transcription. , 2006, Drug discovery today.

[134]  M. Duffy,et al.  Ets2 transcription factor in normal and neoplastic human breast tissue. , 2006, European journal of cancer.

[135]  M. Jinnin,et al.  Upregulation of tenascin-C expression by IL-13 in human dermal fibroblasts via the phosphoinositide 3-kinase/Akt and the protein kinase C signaling pathways. , 2006, The Journal of investigative dermatology.

[136]  W. Leonard,et al.  Maturation stage-specific regulation of megakaryopoiesis by pointed-domain Ets proteins. , 2005, Blood.

[137]  A. Seth,et al.  ETS transcription factors and their emerging roles in human cancer. , 2005, European journal of cancer.

[138]  J. Tchinda,et al.  Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer , 2005, Science.

[139]  Mark E. Davis,et al.  Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. , 2005, Cancer research.

[140]  L. Garrett-Sinha,et al.  Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. , 2005, International immunology.

[141]  S. Arber,et al.  ERM is required for transcriptional control of the spermatogonial stem cell niche , 2005, Nature.

[142]  M. Aoki,et al.  Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model , 2005, Gene Therapy.

[143]  M. Jinnin,et al.  Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1 , 2005, Nucleic acids research.

[144]  Yangzhou Wang,et al.  Analysis of the 2.0 A crystal structure of the protein-DNA complex of the human PDEF Ets domain bound to the prostate specific antigen regulatory site. , 2005, Biochemistry.

[145]  T. Pietsch,et al.  Inactivation of Ets 1 transcription factor by a specific decoy strategy reduces rat C6 glioma cell proliferation and mmp-9 expression. , 2005, International journal of molecular medicine.

[146]  E. McDermott,et al.  Associations and Interactions between Ets-1 and Ets-2 and Coregulatory Proteins, SRC-1, AIB1, and NCoR in Breast Cancer , 2005, Clinical Cancer Research.

[147]  M. Jinnin,et al.  α2(I) collagen gene regulation by protein kinase C signaling in human dermal fibroblasts , 2005, Nucleic acids research.

[148]  I. Rebay,et al.  Post‐translational modifications influence transcription factor activity: A view from the ETS superfamily , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[149]  Barbara J. Graves,et al.  The Structural and Dynamic Basis of Ets-1 DNA Binding Autoinhibition* , 2005, Journal of Biological Chemistry.

[150]  I. Kola,et al.  Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation , 2005, The EMBO journal.

[151]  D. Watson,et al.  Ets-dependent Regulation of Target Gene Expression during Megakaryopoiesis* , 2004, Journal of Biological Chemistry.

[152]  B. Blom,et al.  The ETS Transcription Factor Spi-B Is Required for Human Plasmacytoid Dendritic Cell Development , 2004, The Journal of experimental medicine.

[153]  C. Foulds,et al.  Ras/Mitogen-Activated Protein Kinase Signaling Activates Ets-1 and Ets-2 by CBP/p300 Recruitment , 2004, Molecular and Cellular Biology.

[154]  G. Gilkeson,et al.  Decreased Expression of the Ets Family Transcription Factor Fli-1 Markedly Prolongs Survival and Significantly Reduces Renal Disease in MRL/lpr Mice1 , 2004, The Journal of Immunology.

[155]  M. Duffy,et al.  Overexpression of the Ets-1 transcription factor in human breast cancer , 2004, British Journal of Cancer.

[156]  V. Sementchenko,et al.  SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion , 2004, Oncogene.

[157]  W. Vainchenker,et al.  FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. , 2004, The Journal of clinical investigation.

[158]  Tien Hsu,et al.  Ets proteins in biological control and cancer , 2004, Journal of cellular biochemistry.

[159]  C. Hauser,et al.  Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors* , 2004, Journal of Biological Chemistry.

[160]  A. Sharrocks,et al.  SUMO promotes HDAC-mediated transcriptional repression. , 2004, Molecular cell.

[161]  M. Uesugi,et al.  A wrench-shaped synthetic molecule that modulates a transcription factor-coactivator interaction. , 2004, Journal of the American Chemical Society.

[162]  R. Treisman,et al.  Ternary complex factor SAP-1 is required for Erk-mediated thymocyte positive selection , 2004, Nature Immunology.

[163]  B. Wasylyk,et al.  Ets ternary complex transcription factors. , 2004, Gene.

[164]  Alfred Nordheim,et al.  Mice Deficient for the Ets Transcription Factor Elk-1 Show Normal Immune Responses and Mildly Impaired Neuronal Gene Activation , 2004, Molecular and Cellular Biology.

[165]  A. Wellmann,et al.  Stromal expression of invasion‐promoting, matrix‐degrading proteases MMP‐1 and ‐9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers , 2003, International journal of cancer.

[166]  R. Muise-Helmericks,et al.  Coordinated functions of Akt/PKB and ETS1 in tubule formation , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[167]  R. Janknecht,et al.  Acetylation-Mediated Transcriptional Activation of the ETS Protein ER81 by p300, P/CAF, and HER2/Neu , 2003, Molecular and Cellular Biology.

[168]  V. Sementchenko,et al.  Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. , 2003, Cancer research.

[169]  D. Watson,et al.  Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. , 2003, The American journal of pathology.

[170]  C. Hauser,et al.  Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells. , 2003, The Biochemical journal.

[171]  J. Rossi,et al.  Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[172]  Runzhao Li,et al.  EAPII interacts with ETS1 and modulates its transcriptional function , 2003, Oncogene.

[173]  V. Sementchenko,et al.  The epithelial-specific Ets factors occupy a unique position in defining epithelial proliferation, differentiation and carcinogenesis. , 2003, Anticancer research.

[174]  A. Nordheim,et al.  Protein kinase Calpha regulates Ets1 transcriptional activity in invasive breast cancer cells. , 2003, International journal of oncology.

[175]  Bernard Vandenbunder,et al.  Expression of an Ets-1 dominant-negative mutant perturbs normal and tumor angiogenesis in a mouse ear model , 2003, Oncogene.

[176]  G. Nucifora,et al.  Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[177]  V. Jordan,et al.  Tamoxifen: a most unlikely pioneering medicine , 2003, Nature Reviews Drug Discovery.

[178]  Till Acker,et al.  Cooperative Interaction of Hypoxia-inducible Factor-2α (HIF-2α) and Ets-1 in the Transcriptional Activation of Vascular Endothelial Growth Factor Receptor-2 (Flk-1)* , 2003, The Journal of Biological Chemistry.

[179]  C. Catapano,et al.  Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide. , 2003, Nucleic acids research.

[180]  Edwin J. Weeber,et al.  Pet-1 ETS Gene Plays a Critical Role in 5-HT Neuron Development and Is Required for Normal Anxiety-like and Aggressive Behavior , 2003, Neuron.

[181]  C. Sweep,et al.  Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer , 2002, Oncogene.

[182]  C. Garvie,et al.  Structural Analysis of the Autoinhibition of Ets-1 and Its Role in Protein Partnerships* , 2002, The Journal of Biological Chemistry.

[183]  P. Pandolfi,et al.  The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. , 2002, Immunity.

[184]  J. Darnell.  Transcription factors as targets for cancer therapy , 2002, Nature Reviews Cancer.

[185]  Marc Aumercier,et al.  ETS-1 Transcription Factor Binds Cooperatively to the Palindromic Head to Head ETS-binding Sites of the Stromelysin-1 Promoter by Counteracting Autoinhibition* , 2002, The Journal of Biological Chemistry.

[186]  I. Fidler,et al.  Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. , 2002, Journal of the National Cancer Institute.

[187]  Paul J Hertzog,et al.  Ets1 is required for p53 transcriptional activity in UV‐induced apoptosis in embryonic stem cells , 2002, The EMBO journal.

[188]  V. Sementchenko,et al.  Ets1 Is an Effector of the Transforming Growth Factor β (TGF-β) Signaling Pathway and an Antagonist of the Profibrotic Effects of TGF-β* , 2002, The Journal of Biological Chemistry.

[189]  I. Kola,et al.  Inactivation of the transcription factor Elf3 in mice results in dysmorphogenesis and altered differentiation of intestinal epithelium. , 2002, Gastroenterology.

[190]  M. Duterque-Coquillaud,et al.  When Ets transcription factors meet their partners. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[191]  A. Marotta,et al.  Dysregulation of phosphatidylinositol 3‐kinase and downstream effectors in human breast cancer , 2002, International journal of cancer.

[192]  N. Takai,et al.  c-Ets1 is a promising marker in epithelial ovarian cancer. , 2002, International journal of molecular medicine.

[193]  R. Lutz,et al.  Highly conserved amino acids in Pax and Ets proteins are required for DNA binding and ternary complex assembly. , 2001, Nucleic acids research.

[194]  R. Janknecht,et al.  HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1 , 2001, Oncogene.

[195]  K. Alitalo,et al.  Net‐targeted mutant mice develop a vascular phenotype and up‐regulate egr‐1 , 2001, The EMBO journal.

[196]  Christopher T Denny,et al.  Biology of EWS/ETS fusions in Ewing's family tumors , 2001, Oncogene.

[197]  R. Nicholson,et al.  EGFR and cancer prognosis. , 2001, European journal of cancer.

[198]  A. Wellmann,et al.  Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression. , 2001, International journal of molecular medicine.

[199]  P. Jackers,et al.  Fli-1 Inhibits Collagen Type I Production in Dermal Fibroblasts via an Sp1-dependent Pathway* , 2001, The Journal of Biological Chemistry.

[200]  A. Mushegian,et al.  The Epithelium-specific ETS Protein EHF/ESE-3 Is a Context-dependent Transcriptional Repressor Downstream of MAPK Signaling Cascades* , 2001, The Journal of Biological Chemistry.

[201]  O. Lantz,et al.  Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells. , 2001, Blood.

[202]  A. Wellmann,et al.  The Ets‐1 transcription factor is up‐regulated together with MMP 1 and MMP 9 in the stroma of pre‐invasive breast cancer , 2001, The Journal of pathology.

[203]  W. Folk,et al.  Expression of urokinase plasminogen activator and receptor in conjunction with the ets family and AP-1 complex transcription factors in high grade prostate cancers. , 2001, European journal of cancer.

[204]  Hiroshi Kawada,et al.  Defective Megakaryopoiesis and Abnormal Erythroid Development inFli-1 Gene-Targeted Mice , 2001, International journal of hematology.

[205]  B. Vandenbunder,et al.  The Ets family contains transcriptional activators and repressors involved in angiogenesis. , 2001, The international journal of biochemistry & cell biology.

[206]  F. Soncin,et al.  Rôle des facteurs de transcription ETS dans le contrôle de la spécificité d'expression endothéliale et l'angiogenèse , 2001 .

[207]  Andrew V. Nguyen,et al.  Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.

[208]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[209]  D. Blair,et al.  Ets and retroviruses–transduction and activation of members of the Ets oncogene family in viral oncogenesis , 2000, Oncogene.

[210]  Y. Ben-David,et al.  The role of Fli-1 in normal cell function and malignant transformation , 2000, Oncogene.

[211]  M. Trojanowska.  Ets factors and regulation of the extracellular matrix , 2000, Oncogene.

[212]  V. Sementchenko,et al.  Ets target genes: past, present and future , 2000, Oncogene.

[213]  R. Muise-Helmericks,et al.  Signal transduction and the Ets family of transcription factors , 2000, Oncogene.

[214]  J. Ghysdael,et al.  Proteins of the ETS family with transcriptional repressor activity , 2000, Oncogene.

[215]  Runzhao Li,et al.  Regulation of Ets function by protein–protein interactions , 2000, Oncogene.

[216]  D. Watson,et al.  Hemorrhage, Impaired Hematopoiesis, and Lethality in Mouse Embryos Carrying a Targeted Disruption of the Fli1Transcription Factor , 2000, Molecular and Cellular Biology.

[217]  R Favier,et al.  Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. , 2000, Immunity.

[218]  Runzhao Li,et al.  EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes , 2000, Oncogene.

[219]  M. Nozaki,et al.  Cloning and expression of the mouse Pse gene encoding a novel Ets family member. , 2000, Gene.

[220]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[221]  D. Watson,et al.  Ets transcription factors cooperate with Sp1 to activate the human Tenascin-C promoter , 1999, Oncogene.

[222]  G. Nucifora,et al.  The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A. , 1999, Biochemical and biophysical research communications.

[223]  Jha,et al.  Inhibition of Angiogenesis In Vivo by ets-1 Antisense Oligonucleotides-Inhibition of Ets-1 Transcription Factor Expression by the Antibiotic Fumagillin. , 1999, Angewandte Chemie.

[224]  R. Sood,et al.  Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[225]  S. Shibata,et al.  Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[226]  L. Garrett-Sinha,et al.  PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction. , 1999, Immunity.

[227]  V. Sementchenko,et al.  ETS2 function is required to maintain the transformed state of human prostate cancer cells , 1998, Oncogene.

[228]  Lars S Jermiin,et al.  A novel transcription factor, ELF5, belongs to the ELF subfamily of ETS genes and maps to human chromosome 11p13–15, a region subject to LOH and rearrangement in human carcinoma cell lines , 1998, Oncogene.

[229]  Y Fujiwara,et al.  The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. , 1998, Genes & development.

[230]  K. Fujikawa,et al.  The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor , 1998, International journal of cancer.

[231]  S. Mckercher,et al.  Defective trophoblast function in mice with a targeted mutation of Ets2. , 1998, Genes & development.

[232]  K. Chew,et al.  HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer , 1997, Oncogene.

[233]  J. Westermarck,et al.  Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors , 1997, Oncogene.

[234]  Wen-Lin Kuo,et al.  ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis , 1997, Oncogene.

[235]  N. Bhat,et al.  Expression of ets family of genes in systemic lupus erythematosus and Sjogren's syndrome. , 1996, International journal of oncology.

[236]  T. Graf,et al.  MafB Is an Interaction Partner and Repressor of Ets-1 That Inhibits Erythroid Differentiation , 1996, Cell.

[237]  A. Bernstein,et al.  An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes , 1995, Molecular and cellular biology.

[238]  Todd R. Golub,et al.  Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation , 1994, Cell.

[239]  J. Erickson,et al.  Real‐time DNA binding measurements of the ETSl recombinant oncoproteins reveal significant kinetic differences between the p42 and p51 isoforms , 1994, Protein science : a publication of the Protein Society.

[240]  M. Hendrix,et al.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. , 1994, Science.

[241]  J. Lautenberger,et al.  Inversion of a chicken ets-1 proto-oncogene segment in avian leukemia virus E26 , 1993, Journal of virology.

[242]  P. D. de Jong,et al.  Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints , 1992, Genes, chromosomes & cancer.

[243]  J. Testa,et al.  The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[244]  G. Thomas,et al.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.

[245]  Xianqun Fan,et al.  Putative tumor suppressor miR‐145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene , 2011, Cancer.

[246]  B. Wasylyk,et al.  A review of post-translational modifications and subcellular localization of Ets transcription factors: possible connection with cancer and involvement in the hypoxic response. , 2010, Methods in molecular biology.

[247]  G. Gilkeson,et al.  Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes. , 2008, Molecular immunology.

[248]  Yang Wang,et al.  MicroRNA: past and present. , 2007, Frontiers in bioscience : a journal and virtual library.

[249]  N. Rajewsky,et al.  Deep conservation of microRNA-target relationships and 3'UTR motifs in vertebrates, flies, and nematodes. , 2006, Cold Spring Harbor symposia on quantitative biology.

[250]  C. Laughton,et al.  Selective Inhibition of the Human tie-1 Promoter with Triplex-Forming Oligonucleotides Targeted to Ets Binding Sites , 2006, Molecular medicine.

[251]  D. Watson,et al.  Dysregulation of granulocyte, erythrocyte, and NK cell lineages in Fli-1 gene-targeted mice. , 2005, Blood.

[252]  Peter C. Hollenhorst,et al.  Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. , 2004, Nucleic acids research.

[253]  F. Cavalli,et al.  Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells. , 2004, Nucleic acids research.

[254]  C. Brinckerhoff,et al.  High levels of MMP‐1 expression in the absence of the 2G single nucleotide polymorphism is mediated by p38 and ERK1/2 mitogen‐activated protein kinases in VMM5 melanoma cells , 2002, Journal of cellular biochemistry.

[255]  B. Vandenbunder,et al.  [Transcription factors of the Ets family and morphogenesis of the vascular tree]. , 1999, Journal de la Societe de biologie.

[256]  D. Watson,et al.  Molecular analysis of the ets genes and their products. , 1990, Critical reviews in oncogenesis.